The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease
Open accessAbstract
BACKGROUND: Vascular factors including medical history (heart disease, stroke, diabetes, and hypertension), smoking, and prediagnosis blood lipid measurements (cholesterol: total, high-density lipoprotein, low-density lipoprotein [LDL-C], and triglyceride concentrations) may be predictors for progression of Alzheimer disease (AD). OBJECTIVE: To determine whether prediagnosis vascular risk factors are associated with progression of AD. DESIGN: Inception cohort followed up longitudinally for a mean of 3.5 (up to 10.2) years. SETTING: Washington Heights/Inwood Columbia Aging Project, New York, New York. Patients One hundred fifty-six patients with incident AD (mean age at diagnosis, 83 years). Main Outcome Measure Change in a composite score of cognitive ability from diagnosis onward. RESULTS: In generalized estimating equation models (adjusted for age, race/ethnicity, and years of education), higher cholesterol (total cholesterol and LDL-C) concentrations and history of diabetes were associated with faster cognitive decline. Each 10-U increase in cholesterol and LDL-C was associated with a 0.10-SD decrease in cognitive score per year of follow-up (P < .001 for total cholesterol; P = .001 for LDL-C). High-density lipoprotein cholesterol and triglyceride concentrations were not associated with rate of decline. A history of diabetes was associated with an additional 0.05-SD decrease in cognitive score per year (P = .05). History of heart disease and stroke were associated with cognitive decline only in carriers of the apolipoprotein E epsilon4 (APOE-epsilon4) gene. In a final generalized estimating equation model that included high-density lipoprotein cholesterol and LDL-C concentrations and history of diabetes, only higher LDL-C was independently associated with faster cognitive decline. CONCLUSION: Higher prediagnosis total cholesterol and LDL-C concentrations and history of diabetes were associated with faster cognitive decline in patients with incident AD, which provides further evidence for the role of vascular risk factors in the course of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
The assessment of aphasia and related disorders
Goodglass, H., & Kaplan, E. (1972) · Medical Entomology and Zoology · Cited by 3,258
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Assessment of Aphasia and Related Disorders
Sarno, M. T. (1973) · Physical Therapy · doi:10.1093/ptj/53.2.225b · Cited by 2,242
Statistical Analysis of Correlated Data Using Generalized Estimating Equations: An Orientation
Hanley, J. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf215 · Cited by 2,185
Evaluating storage, retention, and retrieval in disordered memory and learning
BUSCHKE, H., & FULD, P. A. (1974) · Neurology · doi:10.1212/wnl.24.11.1019 · Cited by 1,597
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · cited 1×
“Cerebrovascular lesions, common in patients with AD, may accelerate the clinical manifestation of AD.(30) Vascular risk factors may increase oxidative stress or activate a neuroinflammatory response, triggering amyloid production.”
BackgroundExperience from a multicentre stroke register: a preliminary report.
Hatano, S. (1976) · Europe PMC (PubMed Central) · Cited by 1,526
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Hyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683
Self-citationDiabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682
Self-citationVascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · cited 1×
“An earlier study of the Washington Heights/Inwood Columbia Aging Project cohort found that higher total cholesterol concentration was associated with lower risk of incident AD.(10) The prodromal stage of AD is associated with decreased plasma cholesterol concentrations, possibly owing to dietary insufficiency and weig…”
Self-citationStern, Y. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290035009 · Cited by 369
Self-citationPoststroke Dementia: Clinical Features and Risk Factors
Barba, R., Martínez-Espinosa, S., Rodríguez-García, E., Pondal, M., Vivancos, J., & Del Ser, T. (2000) · Stroke · doi:10.1161/01.str.31.7.1494 · Cited by 362
Education and rates of cognitive decline in incident Alzheimer's disease
Scarmeas, N. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072306 · Cited by 353 · cited 1×
“The z scores were averaged within cognitive domains, which were subsequently averaged to produce the composite cognitive score.(24) The outcome measure was the rate of change in the composite score from diagnosis onward.”
MethodSelf-citationStroke and the Risk of Alzheimer Disease
Honig, L. S., Tang, M.-X., Albert, S., Costa, R., Luchsinger, J., Manly, J., Stern, Y., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1707 · Cited by 343
Self-citationThe relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function
Posner, H. B., Tang, M.-X., Luchsinger, J., Lantigua, R., Stern, Y., & Mayeux, R. (2002) · Neurology · doi:10.1212/wnl.58.8.1175 · Cited by 329
Self-citationVascular factors predict rate of progression in Alzheimer disease
Mielke, M. M., Rosenberg, P. B., Tschanz, J., Cook, L., Corcoran, C., Hayden, K. M., Norton, M., Rabins, P. V., Green, R. C., Welsh-Bohmer, K. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000279520.59792.fe · Cited by 309
Cardiovascular risk factors and Alzheimer’s disease
Luchsinger, J. A., & Mayeux, R. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0056-z · Cited by 238
Self-citationLow-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke
Moroney, J. T. (1999) · JAMA · doi:10.1001/jama.282.3.254 · Cited by 222
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y. (2008) · Neurology · doi:10.1212/01.wnl.0000304038.37421.cc · Cited by 214
Self-citationThe influence of smoking on the risk of Alzheimer’s disease
Merchant, C., Tang, M.-X., Albert, S., Manly, J., Stern, Y., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.52.7.1408 · Cited by 197
Self-citationDeterminants of vascular dementia in the Cardiovascular Health Cognition Study
Kuller, L. H., Lopez, O. L., Jagust, W. J., Becker, J. T., DeKosky, S. T., Lyketsos, C., Kawas, C., Breitner, J. C. S., Fitzpatrick, A., & Dulberg, C. (2005) · Neurology · doi:10.1212/01.wnl.0000160115.55756.de · Cited by 179 · cited 1×
“Previous studies using magnetic resonance imaging and neuropathologic data suggest that, especially in the oldest old, mixed dementia (AD plus vascular dementia) is the most common cause of dementia.(37) Therefore, it is likely that some of our patients with AD actually had mixed dementia.”
The enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
Relationship of vascular risk to the progression of Alzheimer disease
Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G. (2006) · Neurology · doi:10.1212/01.wnl.0000240129.46080.53 · Cited by 141
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease
Masse, I., Bordet, R., Deplanque, D., Khedr, A. A., Richard, F., Libersa, C., & Pasquier, F. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063388 · Cited by 138
Lesort, M. J., & Johnson, G. V. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00200-1 · Cited by 123
Cholesterol and APOE genotype interact to influence Alzheimer disease progression
Evans, R. M., Hui, S. L., Perkins, A. J., Lahiri, D. K., Poirier, J., & Farlow, M. R. (2004) · Neurology · doi:10.1212/01.wnl.0000125323.15458.3f · Cited by 95
The Role of Cerebrovascular Disease in Dementia
DeCarli, C. S. (2003) · The Neurologist · doi:10.1097/00127893-200305000-00001 · Cited by 70
The case for a descriptive generic nomenclature
Lennon, V. A. (1994) · Neurology · doi:10.1212/wnl.44.12.2412 · Cited by 56
The underdiagnosis of the vascular contribution to dementia
Korczyn, A. D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.011 · Cited by 46
The influence of smoking on the risk of Alzheimer's disease
Riggs, J. E., & Merchant, C. (2000) · Neurology · doi:10.1212/wnl.54.3.777-a · Cited by 37
Evaluating storage, retention and retrieval in disordered memory and learning
Herman Buschke, L., & Fuld, P. A. (2011) · Neurology · doi:10.1212/01.wnl.0000398283.10171.75 · Cited by 33
Vascular Risk Factors for Alzheimer’s Disease
Breteler, M. M. B. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_3 · Cited by 13
Stern, Y., Andrews, H. F., Pittman, J. G., Sano, M., Tatemichi, T. K., Lantigua, R., & Mayeux, R. P. (1992) · Archives of Neurology · doi:10.7916/d8v99mkc · Cited by 11
Self-citationAPOE Epsilon 4 Allele Predicts Faster Cognitive Decline in Mild Alzheimer Disease
Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y. (2008) · Neurology · doi:10.7916/d8kh20r3 · Cited by 8
Self-citation
Cited by
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“, atrial fibrillation and congestive heart failure, have also been linked to the pathogenesis and progression of AD and are among the most important modifiable risk factors for AD [35-42].”
BackgroundThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Metadata
- Authors
- Helzner, E. P., Luchsinger, J. A., Scarmeas, N., Cosentino, S., Brickman, A. M., Glymour, M. M., & Stern, Y.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-03-01
- Volume
- 66
- Issue
- 3
- Pages
- 343-8
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2145130062
- Cited by
- 332
- References
- 41
- FWCI
- 22.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.